Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Goldman Sachs Reveals Sectors With Top 2026 Payouts: 5 Strong Buys
11:16am, Monday, 20'th Oct 2025
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest United States corporations by total revenue.
2 Beaten-Down Stocks to Buy and Hold for the Next Decade
09:07am, Monday, 20'th Oct 2025
The market is forward-looking, but investors who earn better-than-average returns often look even further into the future and identify opportunities that are currently being overlooked. That means, am
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of
Merck begins construction of $3 billion manufacturing facility in Virginia
07:07am, Monday, 20'th Oct 2025
Merck said on Monday it has begun construction of a $3 billion pharmaceutical manufacturing facility in Elkton, Virginia as part of its more than $70 billion investment to expand domestic manufacturin
Merck breaks ground on $3B manufacturing plant in Virginia
06:56am, Monday, 20'th Oct 2025
Merck is breaking ground on a new 400,000-square-foot manufacturing facility in Elkton, Virginia, as part of its $70 billion U.S. investment strategy.
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
06:45am, Monday, 20'th Oct 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 KEYNOTE
Pfizer, Merck And Astellas Have An 'Enormous New Hope' For Bladder Cancer Patients
10:30am, Saturday, 18'th Oct 2025
Pharma titans Merck, Pfizer and Astellas Pharma are delivering an "enormous new hope" for patients with an aggressive form of bladder cancer.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating KEYTRUDA® (pembrolizumab) plus Padcev® (enfortu
RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--KEYTRUDA Plus LENVIMA Demonstrates Durable 5-Year Survival Benefit Vs Chemotherapy for Patients With Advanced Endometrial Carcinoma.
Will Declining Gardasil Sales Ail MRK's Top Line in Q3 Earnings?
01:21pm, Friday, 17'th Oct 2025
Merck faces a sharp Gardasil slowdown as weak demand in China and Japan affects sales of the vaccine.
Trump strikes deal with Merck to cut IVF drug prices in return for tariff relief
03:33am, Friday, 17'th Oct 2025
President Donald Trump has unveiled an agreement with Germany's Merck KGaA to lower the cost of its fertility medicines in the United States in exchange for exemptions from threatened tariffs, part o
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?
10:01am, Thursday, 16'th Oct 2025
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Merck: Earnings Outlook Steady, Keytruda Now Has Some Breathing Room
08:00am, Thursday, 16'th Oct 2025
Merck & Co., Inc. remains the largest U.S. pharma company in 2025, driven by oncology and Keytruda, despite looming patent expiration risks. Keytruda accounts for over half of MRK's pharmaceutical rev
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met
